The incidence of clinical apparent cerebral embolism in patients (pts) with atrial fibrillation (AF) who underwent transesophageal echocardiographical (TEE) guided cardioversion is approximately 1%. The incidence of clinically silent cerebral embolism has not been analysed yet. The aims of this prospective studies were (1) to evaluate the prognosis of cardioversion in pts with AF and (2) to assess the incidence of cerebral embolism with MR-imaging (MRI).
Background: Patients (pts) with atrial fibrillation (AF) and spontaneous echo contrast (SEC) have an increased stroke risk. The aims of this prospective study were (1) to evaluate the prognosis of pts with dense SEC and (2) to assess the incidence of cerebral embolism with MR-imaging (MRI) under continued oral anticoagulation therapy. Methods: The study group consisted of 64 pts with SEC and AF. 28 pts served as controls. All pts received oral anticoagulation therapy during the follow-up period (an INR > 2 was defined as effectively anticoagulated). To document the incidence of cerebral embolism all pts underwent the following examinations at admission and at 1, 3 and 12 months: transthoracic and transesophageal echocardiography, cranial MRI including diffusion-weighted MRI, assessment of the anticoagulation level and neurological assessment. Results: 2 pts had clinically silent cerebral embolism at the index examination. Two patients (3%) had cerebral embolism with neurological deficit during the follow-up period. Four (6%) pts died during the observation period due to stroke. Additionally, 6 (9%) pts had new appeared focal diffusion abnormalities in the MRI during the follow-up. 45 (70%) pts were effectively anticoagulated, 15 (23%) pts were anticoagulated inadequately during the 12 months. Pts with cerebral embolism had lower left atrial appendage peak empty velocities (0.22 ± 0.14 vs. 0.38 ± 0.21; p<0.01) and denser SEC (2.8 ± 1.1 vs. 1.6 ± 1.4; p<0.01) than pts without cerebral events. Conclusions: Pts with AF and SEC have an increased risk of cerebral embolism despite oral anticoagulation therapy. Low peak empty velocities of the left atrial appendage and dense SEC are echocardiographic predictors for a cerebral event.
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Cardioversion Background. Atrial fibrillation (AF) is the most common human arrhythmia with a prevalence in the elderly population of up to 15%. It results in breathlessness, palpitations and systemic embolisation due to a procoagulant state. Recent studies of AF have suggested that rate control with anticoagulation may have a superior outcome compared to rhythm control. The aim of this study was to assess the effect of D.C. cardioversion on markers of coagulation and platelet activity and endothelial function in patients with AF on warfarin therapy. Methods Sixty patients undergoing elective D.C cardioversion for non-valvular atrial fibrillation were recruited to the study. All patients were taking warfarin aiming for an INR of 2-3. D.C cardioversion was performed under general anaesthetic following our local protocol. Peripheral venous blood was sampled through a 16G needle prior to cardioversion and at 2,4,6 and 10 weeks post cardioversion provided they remained in sinus rhythm (SR). Warfarin was discontinued 6 weeks after cardioversion. 
